Stock Price
6.10
Daily Change
-1.03 -14.45%
Monthly
-19.74%
Yearly
39.59%
Q2 Forecast
5.99

Silence Therapeutics reported $-12.46M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 7.11B 4.14B Mar/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Novartis USD 4.24B 171M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Silence Therapeutics USD -12.46M 13.78M Dec/2025